|
DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and more than 2,300 generic ingredients from more than 1,700 branded and generic pharmaceutical companies, and more than 4,300 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices. |
Generic Name: alosetron hydrochloride
Summary for Generic Name: alosetron hydrochloride
| |||||||||||||
Clinical Trials for: alosetron hydrochlorideSafety and Efficacy Study of GR68755 (Alosetron Hydrochloride) to Treat Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS) Status: Completed Condition: Irritable Bowel Syndrome (IBS) Study to Assess the Effect Of Alosetron On Mucosal Blood Flow Status: Completed Condition: Irritable Bowel Syndrome (IBS) Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy Status: Completed Condition: Irritable Colon; Irritable Bowel Syndrome (IBS) Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy Status: Completed Condition: Irritable Colon; Irritable Bowel Syndrome (IBS) LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Status: Completed Condition: Irritable Bowel Syndrome Courtesy of ClinicalTrials.org See more clinical trials for this drug | |||||||||||||
Glossary
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Product | Substance | Delist_Flag | Patent Expiration | Patented / Exclusive Use | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prometheus Labs | LOTRONEX | alosetron hydrochloride | TABLET; ORAL | 021107 | Feb 9, 2000 | RX | Yes | 6,284,770 | <disabled> | FOR WOMEN WITH SEVERE DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Prometheus Labs | LOTRONEX | alosetron hydrochloride | TABLET; ORAL | 021107 | Feb 9, 2000 | RX | Yes | 5,360,800 | Y | Y | <disabled> | FOR WOMEN WITH SEVERE DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Prometheus Labs | LOTRONEX | alosetron hydrochloride | TABLET; ORAL | 021107 | Dec 23, 2003 | RX | No | 6,284,770 | <disabled> | FOR WOMEN WITH SEVERE DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Prometheus Labs | LOTRONEX | alosetron hydrochloride | TABLET; ORAL | 021107 | Dec 23, 2003 | RX | No | 5,360,800 | Y | Y | <disabled> | FOR WOMEN WITH SEVERE DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The preview shows a limited data set. Complete access is available with a Subscription | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
« Back to Dashboard
DrugPatentWatch Archives
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Connect with Social Media:
Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639
`abc